| Market Cap | ₹11Cr |
| ROE | 23.59% |
| P/E Ratio(TTM) | 10.91 |
| EPS(TTM) | 2.29 |
| P/B Ratio | 2.58 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.10 |
| Book Value | 9.70 |
| Debt to Equity | 0.00 |
| Face Value | 10 |
| Parent Organisation | Unjha Formulations Limited |
| BSE Symbol | 531762 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.10 | ||
| Ajanta Pharma | NA (0.00%) | 33.65 | ||
| Gland Pharma | NA (0.00%) | 34.84 | ||
| Eris Lifesciences | NA (0.00%) | 47.73 |